![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Qiagen Gains CE Mark for COVID-19 Test That Measures T-Cell Response
Qiagen Gains CE Mark for COVID-19 Test That Measures T-Cell Response
Qiagen’s Quantiferon SARS-CoV-2 assay, which measures T-cell responses to the SARS-CoV-2 virus, has received a CE mark.
The assay detects CD4+ and CD8+ T-cell responses, which allows a more comprehensive assessment of immunity generated by COVID-19 vaccines, especially in vulnerable individuals.
T-cell response to the virus declines more slowly than antibody responses and may indicate how severe the course of COVID-19 will be in infected patients.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct